
Sign up to save your podcasts
Or


AdAlta: A big development for fibrosis sufferers … and it could be lucrative too
Listen to ASX-listed AdAlta Managing Director Tim Oldham talk to Matt Birney on the Bulls N’ Bears Report about AdAlta’s extraordinary new drug that just might be a game changer for fibrosis sufferers.
See omnystudio.com/listener for privacy information.
By Bulls N' Bears on 6PR RadioAdAlta: A big development for fibrosis sufferers … and it could be lucrative too
Listen to ASX-listed AdAlta Managing Director Tim Oldham talk to Matt Birney on the Bulls N’ Bears Report about AdAlta’s extraordinary new drug that just might be a game changer for fibrosis sufferers.
See omnystudio.com/listener for privacy information.

56 Listeners

22 Listeners

61 Listeners

29 Listeners

22 Listeners

2 Listeners

4 Listeners

5 Listeners

2 Listeners

9 Listeners